Scientific Poster , Human ADME , Clinical Pharmacology

ISSX 2017 Poster: Using 14C radiolabeled clinical studies to explore and evaluate factors influencing oral exposure

6 November 2017
  • Home
  • Resources
  • ISSX 2017 Poster: Using 14C radiolabeled clinical studies to explore and evaluate factors influencing oral exposure
Overview

This poster describes a 2 part study combining an IV microtracer study with a conventional oral ADME study.

Read our ISSX scientific poster today titled, 'Using 14C Radiolabeled Clinical Studies to Explore and Evaluate Factors Influencing Oral Exposure.'

Download
Download Now
Date
6 November 2017

Your challenges. Our solutions.

Learn more about our expertise in human ADME studies.

Contact Us
Quotient Sciences Logo
Human ADME, Regulatory, Dr. Adam Robinson-Miller

Assessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyond

By: Dr. Adam Robinson-Miller Read More

More about our human ADME capabilities

Browse More
Info Sheet, Human ADME, Radiosynthesis, Clinical Pharmacology
Human ADME Capabilities
Download Now
Whitepaper, Human ADME
Synthesis-to-Clinic®: A streamlined approach to 14C human ADME studies
Download Now
Browse More
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk